Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Introductory guidance on choosing long-term holds for beginners, focusing on fundamentals, liquidity, and project viability.
27,784 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A leading economist warns that renewed hostilities with Iran could trigger a butterfly effect in global markets, keep...
A Friday executive order on mortgages is reshaping regulatory expectations, prioritizing smaller lenders while drawin...
IBM’s leadership points to a quicker, clearer regulatory path for mergers and acquisitions, citing the Confluent purc...
TD Cowen raises its Strategy price target to 395, driven by a shift toward STRC issuance and an improved BTC yield ou...
TSMC delivered a stronger-than-expected Q1 2026, lifting full-year targets as AI demand powers the cycle, fueling the...
AI reshapes entry-level work as automation accelerates, pushing colleges to rethink internships and hands-on experien...
Institutional funds continue to flow into XRP as Citadel joins Ripple’s latest funding round, sparking expectations t...
UBS contends that the math behind DeSantis' flagship property tax relief may not deliver the promised relief. Florida...
A 59-year-old faces a six-figure tax bill after an indirect IRA rollover violated the once-per-year rollover rule 59-...
New analysis shows the Trump family generated roughly $2.3 billion in pretax crypto income from late 2024 through Apr...
Motor oil prices are rising as geopolitical tensions around Iran disrupt supply chains. Even with a tentative deal on...